AQST: Aquestive Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based in NJ, United States.

Info & Links

CEO

Daniel Barber

Headquarters

30 TECHNOLOGY DRIVE
WARREN, NJ 07059, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

142

Aquestive Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

339.70M

Enterprise Value

304.79M

Enterprise Value/EBITDA(ttm)

-10.25

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.74

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

66.19%

Operating Margin(ttm)

-59.75%

Profit Margin(ttm)

-126.33%

Return on Equity(ttm)

Return on Invested Capital(ttm)

277.41%

Return on Assets(ttm)

-33.96%

Income Statement

Revenue(ttm)

54.23M

Revenue Per Share(ttm)

0.55

Gross Profit(ttm)

37.09M

EBITDA(ttm)³

-29.74M

Net Income Available to Common(ttm)

-54.24M

Diluted EPS(ttm)

-0.45

Share Statistics

Beta (5Y Monthly)

2.67

52-Week Change

26.95%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

99.33M

Dividend Yield

0.00%

Float⁴

84.02M

% Held by Insiders

7.85%

% Held by Institutions

32.45%

Balance Sheet

Total Cash(mrq)

68.66M

Total Cash Per Share(mrq)

0.69

Total Debt(mrq)

33.75M

Total Debt/Equity(mrq)

-55.38%

Current Ratio(mrq)

4.87%

Quick Ratio(mrq)

5.91%

Book Value Per Share(mrq)

-0.61

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.24

Free Cash Flow(ytd)

-23.54M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AQST

Aquestive Therapeutics, Inc. Common Stock

Aquestive Therapeutics, Inc. Common Stock Profile